PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $245,000 | -56.1% | 6,440 | -50.4% | 0.00% | -75.0% |
| Q4 2018 | $558,000 | +93.8% | 12,980 | +115.2% | 0.00% | +100.0% |
| Q3 2018 | $288,000 | +9.1% | 6,031 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $264,000 | +20.5% | 5,794 | -0.6% | 0.00% | 0.0% |
| Q3 2017 | $219,000 | -14.1% | 5,829 | +8.9% | 0.00% | 0.0% |
| Q2 2017 | $255,000 | +7.1% | 5,355 | +2.7% | 0.00% | 0.0% |
| Q1 2017 | $238,000 | – | 5,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |